The HCPLive spondyloarthritis page is a resource for medical news and expert insights on spondylitis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for autoimmune disease, and more.
June 7th 2024
Patients in the active counseling group were more likely to achieve low disease activity or remission.
Black People Underrepresented in Pivotal Inflammatory Arthritis Clinical Trials
October 26th 2023While Black people are consistently underrepresented, White people are consistently overrepresented in inflammatory arthritis trials for rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, and juvenile idiopathic arthritis.
Xenofon Baraliakos, MD, PhD: Efficacy of Upadacitinib for Treating Active Ankylosing Spondylitis
Results of the SELECT-AXIS 2 study supported the efficacy and safety profile of upadacitinib in patients with active ankylosing spondylitis who had an inadequate response to biologic DMARD therapy.
Filip Van den Bosch, MD: Safety and Efficacy of Upadacitinib for nr-axSpA
Filip Van den Bosch, MD, discusses his presentation, “Efficacy and Safety of Upadacitinib in Patients With Active Non-Radiographic Axial Spondyloarthritis: a Double-Blind, Randomized, Placebo-Controlled Phase 3 Trial."
Improve Shared Decision Making Between Providers and Patients with Rheumatic Disease
June 1st 2022Research presented at EULAR aims to enhance communication with a conversation aid so patients can address challenges they encounter as a result of rheumatic and musculoskeletal disease with a rheumatologist.